Literature DB >> 12704275

Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke.

Patricia C Gregory1, Keith V Kuhlemeier.   

Abstract

OBJECTIVE: Deep venous thromboembolism (DVT) is an important health issue in the hospitalized geriatric population that leads to increased length of stay, morbidity, and mortality. Patients with hemorrhagic strokes are usually not placed on prophylactic therapy because of the risk of hemorrhagic extension of the stroke. The purpose of this study was to evaluate the prevalence of DVTs in hospitalized patients with hemorrhagic vs. thromboembolic strokes.
DESIGN: Retrospective chart review of data obtained from the Maryland Health Services Cost Review Commission data base for 1999 to determine the prevalence of DVTs in both hemorrhagic and thromboembolic stroke patients hospitalized acutely. Multiple logistic regression was performed to evaluate possible risk factors.
RESULTS: There were 1926 patients hospitalized with a primary diagnosis of hemorrhagic stroke and 15599 with thromboembolic stroke. Women in general had more strokes than men did. Older patients were more likely to have strokes as evidenced by the mean ages of 66 and 71 yr for hemorrhagic and thromboembolic strokes, respectively. A total of 37 patients (1.9%) with hemorrhagic strokes had DVTs, whereas 74 patients (0.5%) with thromboembolic strokes had DVTs. Hemorrhagic stroke was an independent risk factor for DVT (odds ratio, 2.60; 95% confidence interval, 1.49-4.55; P = 0.0008).
CONCLUSIONS: DVT prevalence and risk was higher among patients with hemorrhagic strokes in comparison with patients with thromboembolic strokes.

Entities:  

Mesh:

Year:  2003        PMID: 12704275     DOI: 10.1097/01.PHM.0000064725.62897.A5

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  13 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group.

Authors:  Daniel B Herrick; Wendy C Ziai; Carol B Thompson; Karen Lane; Nichol A McBee; Daniel F Hanley
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

Review 3.  [Deep vein thrombosis and lung embolisms in patients with stroke: prevention and therapy].

Authors:  J Trabert; T Steiner
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

4.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

5.  Inferior Vena Cava Thrombosis Related to Hypothermia Catheter: Report of 20 Consecutive Cases.

Authors:  Andres Reccius; Pablo Mercado; Patricio Vargas; Claudio Canals; Jose Montes
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

Review 6.  Cardiovascular Events After Intracerebral Hemorrhage.

Authors:  Linxin Li; Santosh B Murthy
Journal:  Stroke       Date:  2022-06-08       Impact factor: 10.170

Review 7.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 8.  Prophylaxis for venous thrombo-embolism in neurocritical care: a critical appraisal.

Authors:  Ahmed M Raslan; Jeremy D Fields; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

9.  High Plasma Levels of D-Dimer Are Independently Associated with a Heightened Risk of Deep Vein Thrombosis in Patients with Intracerebral Hemorrhage.

Authors:  Xuan Cheng; Lu Zhang; Nan-Chang Xie; Yun-Qing Ma; Ya-Jun Lian
Journal:  Mol Neurobiol       Date:  2015-10-21       Impact factor: 5.590

10.  Early chemoprophylaxis for deep venous thrombosis does not increase the risk of hematoma expansion in patients presenting with spontaneous intracerebral hemorrhage.

Authors:  Dimitri Laurent; Olgert Bardhi; Paul Kubilis; Brian Corliss; Stephanie Adamczak; Ndi Geh; William Dodd; Sasha Vaziri; Katharina Busl; W Christopher Fox
Journal:  Surg Neurol Int       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.